7,640
Views
36
CrossRef citations to date
0
Altmetric
Editorial

Valbenazine granted breakthrough drug status for treating tardive dyskinesia

, MD

Figures & data

Figure 1. Metabolism of valbenazine to its active derivative (+)-dihydrotetrabenazine (DHTBZ).

Figure 1. Metabolism of valbenazine to its active derivative (+)-dihydrotetrabenazine (DHTBZ).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.